SFr. 140.00
€ 151.20
BTC 0.0026
LTC 2.099
ETH 0.0532


bestellen

Artikel-Nr. 18779295


Diesen Artikel in meine
Wunschliste
Diesen Artikel
weiterempfehlen
Diesen Preis
beobachten

Weitersagen:


Herausgeber: 
  • Evan B. Siegel
  • Development and Approval of Combination Products: A Regulatory Perspective 
     

    (Buch)
    Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!


    Übersicht

    Auf mobile öffnen
     
    Lieferstatus:   Auf Bestellung (Lieferzeit unbekannt)
    Veröffentlichung:  Juni 2008  
    Genre:  Naturwissensch., Medizin, Technik 
     
    Apparatetechnik u. Biosensoren / Arzneimittelentwicklung / Bioinstrumentation & Biosensors / Biomedical engineering / Biomedizintechnik / Chemie / chemistry / Drug Discovery & Development / Medical Science / Medizin / Pharmacology & Pharmaceutical Medicine / Pharmakologie u. Pharmazeutische Medizin / Wirkstoffforschung u. -entwicklung
    ISBN:  9780470050941 
    EAN-Code: 
    9780470050941 
    Verlag:  Wiley 
    Einband:  Gebunden  
    Sprache:  English  
    Dimensionen:  H 240 mm / B 161 mm / D 19 mm 
    Gewicht:  517 gr 
    Seiten:  232 
    Bewertung: Titel bewerten / Meinung schreiben
    Inhalt:
    A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it also sets forth the most efficient and effective path to FDA approval. The book begins with an introductory chapter presenting definitions and basic regulatory principles of combination products. Next, it reviews manufacturing and controls, preclinical testing models, pharmacology, clinical testing, regulatory submissions, FDA reviews, and approvals. Among the key topics examined are: * The pharmacology, safety pharmacology, and toxicology supporting human clinical trials of combination products * Approaches to clinical trial protocol design and execution * Chemical, physicochemical, and analytical aspects of manufacturing controls and validation that lead to stable components for combination products * Key sponsor/FDA meetings and negotiations essential for approval and commercialization Case studies involving such actual combination products as Mylotarg, Herceptin, and HercepTest help you better understand how to implement the author's practical guidelines. References at the end of each chapter enable you to find more information on any stage of the development, manufacturing and approval processes. This book is ideal for researchers, regulators, academics, project managers, and executives involved in the complex process of combination product development. Not only does itoffer a comprehensive guide to the technical aspects of the field, it also integrates all ofthese technical aspects into a unified, effective approach to help ensure a successful, approved product.

      



    Wird aktuell angeschaut...
     

    Zurück zur letzten Ansicht


    AGB | Datenschutzerklärung | Mein Konto | Impressum | Partnerprogramm
    Newsletter | 1Advd.ch RSS News-Feed Newsfeed | 1Advd.ch Facebook-Page Facebook | 1Advd.ch Twitter-Page Twitter
    Forbidden Planet AG © 1999-2024
    Alle Angaben ohne Gewähr
     
    SUCHEN

     
     Kategorien
    Im Sortiment stöbern
    Genres
    Hörbücher
    Aktionen
     Infos
    Mein Konto
    Warenkorb
    Meine Wunschliste
     Kundenservice
    Recherchedienst
    Fragen / AGB / Kontakt
    Partnerprogramm
    Impressum
    © by Forbidden Planet AG 1999-2024